Find clinical trials for Multiple Myeloma in Taipei City
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Taipei City, TWN:
The goal of this clinical trial is to learn if the antibody drug HuL001, combined withLenalidomide/Dexamethasone works to treat Multiple Myeloma...
Phase 1, Phase 2
Taipei, Taiwan
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...
Phase 4
Taipei, Taiwan and 15 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Taipei, Taiwan and 211 other locations
Unconjugated belantamab antibody in participants with refractory multiple myeloma (RRMM) who have received at least 3 prior therapi...
Phase 1, Phase 2
Taipei, Taiwan and 26 other locations
The purpose of this clinical trial is to (1) learn whether the BCMA-CD3 bispecific antibody elranatamab can provide more benefit to people with multiple...
Phase 3
Taipei, Taiwan and 97 other locations
with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...
Phase 3
Taipei, Taiwan and 265 other locations
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...
Phase 3
Taipei City, Taipei, Taiwan and 165 other locations
Elranatamab is a bispecific antibody: binding of elranatamab to CD3-expressing T-cells and BCMA-expressing multiple myeloma cells c...
Phase 3
Taipei, Taiwan and 39 other locations
The purpose of this Phase 3 study is to evaluate if BRd prolongs progression free survival (PFS) and/or improves minimal residual disease (MRD) negat...
Phase 3
Taipei, Taiwan and 180 other locations
tolerability at RP2D in Part 2 (dose expansion) in participants with multiple myeloma (MM) whose disease has come back after treatm...
Phase 1
Taipei, Taiwan and 14 other locations
Clinical trials
Research sites
Resources
Legal